Showing results (271-280 of 589) with videos related to

Sort By:
Pageof 59
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 26, 2018
Radiotherapy of relapse-refractory follicular lymphomaÉ Grignano, B Deau-Fischer, G Loganadane, et al.
Neurochemistry International|October 7, 2008
Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disordersPolina Petkova-Kirova, Angelina Rakovska, Galina Zaekova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2013
Whole breast radiotherapy in the lateral decubitus position: a dosimetric and clinical solution to decrease the doses to the organs at risk (OAR)Youlia M Kirova, Tarek Hijal, Francois Campana, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2017
Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic reviewFabien Mignot, Zahra Ajgal, Hoping Xu, et al.
Developmental Cell|July 9, 2022
A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phaseDilyana Georgieva Kirova, Kristyna Judasova, Julia Vorhauser, et al.
General Physiology and Biophysics|August 18, 2001
Thyrotropin-releasing hormone activates KCa channels in gastric smooth muscle cells via intracellular Ca2+ releaseP S Petkova-Kirova, L T Lubomirov, H S Gagov, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 10, 2018
[Evaluation of an automatic delineation system for organs at risk and target lymph nodes volumes for patients treated for breast cancer]A Arsène-Henry, H-P Xu, M Robilliard, et al.
The Journal of Physiology|November 18, 2006
Dispersion of repolarization and refractoriness are determinants of arrhythmia phenotype in transgenic mice with long QTBarry London, Linda C Baker, Polina Petkova-Kirova, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 10, 2013
[Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer]X Liem, C Chira, A Fourquet, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework RecommendationEmuella Flood, Niklas Karlsson, Jennifer Ostridge, et al.
Pageof 59